Thirty years ago, Jean Walsh was diagnosed with Friedreich’s ataxia (FA) — a debilitating, life-shortening, degenerative neuro-muscular disorder. There was little understanding of the disease at the time, and no promise for a cure. Today, a number of Massachusetts biotech companies, such as Voyager Therapeutics, are giving patients like Walsh hope.


Read more: MassBio News Patient Profile: Jean Walsh